Industry Research Reports
Home > Reports > Medical Devices & Consumables > Interventional Ventricular Assist Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Interventional Ventricular Assist Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 107 Pages
Report ld: 4619306
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Interventional Ventricular Assist Devices Market Size(US$)
CAGR 2025-2031
12.1%
Market Size,2031
USD 3,624
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,826 million
Market Forecast in 2031(Value)
US$ 3,624 million
CAGR
12.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Interventional Ventricular Assist Devices was estimated to be worth US$ 1647 million in 2024 and is forecast to a readjusted size of US$ 3624 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Interventional Ventricular Assist Devices are minimally invasive cardiac assist devices designed to provide temporary circulatory support during cardiac surgery or the treatment of acute heart failure. These systems, implanted through sophisticated interventional procedures, are capable of assisting pumping blood in or around the heart to maintain blood circulation, buying patients time to recover or serving as a bridge to long-term treatment. The operation of IVADs relies on an external power supply and control unit, which can be rapidly deployed to provide immediate hemodynamic support to the patient.
North American market for Interventional Ventricular Assist Devices was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Interventional Ventricular Assist Devices was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Interventional Ventricular Assist Devices was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Interventional Ventricular Assist Devices include Abiomed, Inc., LivaNova, Inc, Levitronix, HeartWare International Pty Ltd, PulseCath, Magenta Medical, Shenzhen Hanuo Medical Technology Co., Ltd, Shanghai Newmed Medical Technology Co., Ltd, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Interventional Ventricular Assist Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Interventional Ventricular Assist Devices by region & country, by Type, and by Application.
The Interventional Ventricular Assist Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Ventricular Assist Devices.
MARKET SEGMENTATION
By Company
- Abiomed, Inc.
- LivaNova, Inc
- Levitronix
- HeartWare International Pty Ltd
- PulseCath
- Magenta Medical
- Shenzhen Hanuo Medical Technology Co., Ltd
- Shanghai Newmed Medical Technology Co., Ltd
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 2.5L/min
- 3.5L/min
- 5.0L/min
- 5.5L/min
Segment by Application
- Public Hospitals
- Private Hospital
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Interventional Ventricular Assist Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Interventional Ventricular Assist Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Interventional Ventricular Assist Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Interventional Ventricular Assist Devices Product Introduction
1.2 Global Interventional Ventricular Assist Devices Market Size Forecast
1.2.1 Global Interventional Ventricular Assist Devices Sales Value (2020-2031)
1.2.2 Global Interventional Ventricular Assist Devices Sales Volume (2020-2031)
1.2.3 Global Interventional Ventricular Assist Devices Sales Price (2020-2031)
1.3 Interventional Ventricular Assist Devices Market Trends & Drivers
1.3.1 Interventional Ventricular Assist Devices Industry Trends
1.3.2 Interventional Ventricular Assist Devices Market Drivers & Opportunity
1.3.3 Interventional Ventricular Assist Devices Market Challenges
1.3.4 Interventional Ventricular Assist Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Interventional Ventricular Assist Devices Players Revenue Ranking (2024)
2.2 Global Interventional Ventricular Assist Devices Revenue by Company (2020-2025)
2.3 Global Interventional Ventricular Assist Devices Players Sales Volume Ranking (2024)
2.4 Global Interventional Ventricular Assist Devices Sales Volume by Company Players (2020-2025)
2.5 Global Interventional Ventricular Assist Devices Average Price by Company (2020-2025)
2.6 Key Manufacturers Interventional Ventricular Assist Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Interventional Ventricular Assist Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Interventional Ventricular Assist Devices
2.9 Interventional Ventricular Assist Devices Market Competitive Analysis
2.9.1 Interventional Ventricular Assist Devices Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Interventional Ventricular Assist Devices Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Ventricular Assist Devices as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 2.5L/min
3.1.2 3.5L/min
3.1.3 5.0L/min
3.1.4 5.5L/min
3.2 Global Interventional Ventricular Assist Devices Sales Value by Type
3.2.1 Global Interventional Ventricular Assist Devices Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Interventional Ventricular Assist Devices Sales Value, by Type (2020-2031)
3.2.3 Global Interventional Ventricular Assist Devices Sales Value, by Type (%) (2020-2031)
3.3 Global Interventional Ventricular Assist Devices Sales Volume by Type
3.3.1 Global Interventional Ventricular Assist Devices Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Interventional Ventricular Assist Devices Sales Volume, by Type (2020-2031)
3.3.3 Global Interventional Ventricular Assist Devices Sales Volume, by Type (%) (2020-2031)
3.4 Global Interventional Ventricular Assist Devices Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Public Hospitals
4.1.2 Private Hospital
4.2 Global Interventional Ventricular Assist Devices Sales Value by Application
4.2.1 Global Interventional Ventricular Assist Devices Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Interventional Ventricular Assist Devices Sales Value, by Application (2020-2031)
4.2.3 Global Interventional Ventricular Assist Devices Sales Value, by Application (%) (2020-2031)
4.3 Global Interventional Ventricular Assist Devices Sales Volume by Application
4.3.1 Global Interventional Ventricular Assist Devices Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Interventional Ventricular Assist Devices Sales Volume, by Application (2020-2031)
4.3.3 Global Interventional Ventricular Assist Devices Sales Volume, by Application (%) (2020-2031)
4.4 Global Interventional Ventricular Assist Devices Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Interventional Ventricular Assist Devices Sales Value by Region
5.1.1 Global Interventional Ventricular Assist Devices Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Interventional Ventricular Assist Devices Sales Value by Region (2020-2025)
5.1.3 Global Interventional Ventricular Assist Devices Sales Value by Region (2026-2031)
5.1.4 Global Interventional Ventricular Assist Devices Sales Value by Region (%), (2020-2031)
5.2 Global Interventional Ventricular Assist Devices Sales Volume by Region
5.2.1 Global Interventional Ventricular Assist Devices Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Interventional Ventricular Assist Devices Sales Volume by Region (2020-2025)
5.2.3 Global Interventional Ventricular Assist Devices Sales Volume by Region (2026-2031)
5.2.4 Global Interventional Ventricular Assist Devices Sales Volume by Region (%), (2020-2031)
5.3 Global Interventional Ventricular Assist Devices Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Interventional Ventricular Assist Devices Sales Value, 2020-2031
5.4.2 North America Interventional Ventricular Assist Devices Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Interventional Ventricular Assist Devices Sales Value, 2020-2031
5.5.2 Europe Interventional Ventricular Assist Devices Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Interventional Ventricular Assist Devices Sales Value, 2020-2031
5.6.2 Asia Pacific Interventional Ventricular Assist Devices Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Interventional Ventricular Assist Devices Sales Value, 2020-2031
5.7.2 South America Interventional Ventricular Assist Devices Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Interventional Ventricular Assist Devices Sales Value, 2020-2031
5.8.2 Middle East & Africa Interventional Ventricular Assist Devices Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Interventional Ventricular Assist Devices Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Interventional Ventricular Assist Devices Sales Value and Sales Volume
6.2.1 Key Countries/Regions Interventional Ventricular Assist Devices Sales Value, 2020-2031
6.2.2 Key Countries/Regions Interventional Ventricular Assist Devices Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Interventional Ventricular Assist Devices Sales Value, 2020-2031
6.3.2 United States Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Interventional Ventricular Assist Devices Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Interventional Ventricular Assist Devices Sales Value, 2020-2031
6.4.2 Europe Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Interventional Ventricular Assist Devices Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Interventional Ventricular Assist Devices Sales Value, 2020-2031
6.5.2 China Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
6.5.3 China Interventional Ventricular Assist Devices Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Interventional Ventricular Assist Devices Sales Value, 2020-2031
6.6.2 Japan Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Interventional Ventricular Assist Devices Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Interventional Ventricular Assist Devices Sales Value, 2020-2031
6.7.2 South Korea Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Interventional Ventricular Assist Devices Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Interventional Ventricular Assist Devices Sales Value, 2020-2031
6.8.2 Southeast Asia Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Interventional Ventricular Assist Devices Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Interventional Ventricular Assist Devices Sales Value, 2020-2031
6.9.2 India Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
6.9.3 India Interventional Ventricular Assist Devices Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abiomed, Inc.
7.1.1 Abiomed, Inc. Company Information
7.1.2 Abiomed, Inc. Introduction and Business Overview
7.1.3 Abiomed, Inc. Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Abiomed, Inc. Interventional Ventricular Assist Devices Product Offerings
7.1.5 Abiomed, Inc. Recent Development
7.2 LivaNova, Inc
7.2.1 LivaNova, Inc Company Information
7.2.2 LivaNova, Inc Introduction and Business Overview
7.2.3 LivaNova, Inc Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 LivaNova, Inc Interventional Ventricular Assist Devices Product Offerings
7.2.5 LivaNova, Inc Recent Development
7.3 Levitronix
7.3.1 Levitronix Company Information
7.3.2 Levitronix Introduction and Business Overview
7.3.3 Levitronix Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Levitronix Interventional Ventricular Assist Devices Product Offerings
7.3.5 Levitronix Recent Development
7.4 HeartWare International Pty Ltd
7.4.1 HeartWare International Pty Ltd Company Information
7.4.2 HeartWare International Pty Ltd Introduction and Business Overview
7.4.3 HeartWare International Pty Ltd Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 HeartWare International Pty Ltd Interventional Ventricular Assist Devices Product Offerings
7.4.5 HeartWare International Pty Ltd Recent Development
7.5 PulseCath
7.5.1 PulseCath Company Information
7.5.2 PulseCath Introduction and Business Overview
7.5.3 PulseCath Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 PulseCath Interventional Ventricular Assist Devices Product Offerings
7.5.5 PulseCath Recent Development
7.6 Magenta Medical
7.6.1 Magenta Medical Company Information
7.6.2 Magenta Medical Introduction and Business Overview
7.6.3 Magenta Medical Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Magenta Medical Interventional Ventricular Assist Devices Product Offerings
7.6.5 Magenta Medical Recent Development
7.7 Shenzhen Hanuo Medical Technology Co., Ltd
7.7.1 Shenzhen Hanuo Medical Technology Co., Ltd Company Information
7.7.2 Shenzhen Hanuo Medical Technology Co., Ltd Introduction and Business Overview
7.7.3 Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Offerings
7.7.5 Shenzhen Hanuo Medical Technology Co., Ltd Recent Development
7.8 Shanghai Newmed Medical Technology Co., Ltd
7.8.1 Shanghai Newmed Medical Technology Co., Ltd Company Information
7.8.2 Shanghai Newmed Medical Technology Co., Ltd Introduction and Business Overview
7.8.3 Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Offerings
7.8.5 Shanghai Newmed Medical Technology Co., Ltd Recent Development
8 Industry Chain Analysis
8.1 Interventional Ventricular Assist Devices Industrial Chain
8.2 Interventional Ventricular Assist Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Interventional Ventricular Assist Devices Sales Model
8.5.2 Sales Channel
8.5.3 Interventional Ventricular Assist Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Interventional Ventricular Assist Devices Market Trends
Table 2. Interventional Ventricular Assist Devices Market Drivers & Opportunity
Table 3. Interventional Ventricular Assist Devices Market Challenges
Table 4. Interventional Ventricular Assist Devices Market Restraints
Table 5. Global Interventional Ventricular Assist Devices Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Interventional Ventricular Assist Devices Revenue Market Share by Company (2020-2025)
Table 7. Global Interventional Ventricular Assist Devices Sales Volume by Company (2020-2025) & (Units)
Table 8. Global Interventional Ventricular Assist Devices Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Interventional Ventricular Assist Devices Price by Company (2020-2025) & (K US$/Unit)
Table 10. Key Manufacturers Interventional Ventricular Assist Devices Manufacturing Base and Headquarters
Table 11. Key Manufacturers Interventional Ventricular Assist Devices Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Interventional Ventricular Assist Devices
Table 13. Global Interventional Ventricular Assist Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Ventricular Assist Devices as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Interventional Ventricular Assist Devices Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Interventional Ventricular Assist Devices Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Interventional Ventricular Assist Devices Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Interventional Ventricular Assist Devices Sales Market Share in Value by Type (2020-2025)
Table 20. Global Interventional Ventricular Assist Devices Sales Market Share in Value by Type (2026-2031)
Table 21. Global Interventional Ventricular Assist Devices Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
Table 22. Global Interventional Ventricular Assist Devices Sales Volume by Type (2020-2025) & (Units)
Table 23. Global Interventional Ventricular Assist Devices Sales Volume by Type (2026-2031) & (Units)
Table 24. Global Interventional Ventricular Assist Devices Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Interventional Ventricular Assist Devices Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Interventional Ventricular Assist Devices Price by Type (2020-2025) & (K US$/Unit)
Table 27. Global Interventional Ventricular Assist Devices Price by Type (2026-2031) & (K US$/Unit)
Table 28. Global Interventional Ventricular Assist Devices Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Interventional Ventricular Assist Devices Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Interventional Ventricular Assist Devices Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Interventional Ventricular Assist Devices Sales Market Share in Value by Application (2020-2025)
Table 32. Global Interventional Ventricular Assist Devices Sales Market Share in Value by Application (2026-2031)
Table 33. Global Interventional Ventricular Assist Devices Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
Table 34. Global Interventional Ventricular Assist Devices Sales Volume by Application (2020-2025) & (Units)
Table 35. Global Interventional Ventricular Assist Devices Sales Volume by Application (2026-2031) & (Units)
Table 36. Global Interventional Ventricular Assist Devices Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Interventional Ventricular Assist Devices Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Interventional Ventricular Assist Devices Price by Application (2020-2025) & (K US$/Unit)
Table 39. Global Interventional Ventricular Assist Devices Price by Application (2026-2031) & (K US$/Unit)
Table 40. Global Interventional Ventricular Assist Devices Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Interventional Ventricular Assist Devices Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Interventional Ventricular Assist Devices Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Interventional Ventricular Assist Devices Sales Value by Region (2020-2025) & (%)
Table 44. Global Interventional Ventricular Assist Devices Sales Value by Region (2026-2031) & (%)
Table 45. Global Interventional Ventricular Assist Devices Sales Volume by Region (Units): 2020 VS 2024 VS 2031
Table 46. Global Interventional Ventricular Assist Devices Sales Volume by Region (2020-2025) & (Units)
Table 47. Global Interventional Ventricular Assist Devices Sales Volume by Region (2026-2031) & (Units)
Table 48. Global Interventional Ventricular Assist Devices Sales Volume by Region (2020-2025) & (%)
Table 49. Global Interventional Ventricular Assist Devices Sales Volume by Region (2026-2031) & (%)
Table 50. Global Interventional Ventricular Assist Devices Average Price by Region (2020-2025) & (K US$/Unit)
Table 51. Global Interventional Ventricular Assist Devices Average Price by Region (2026-2031) & (K US$/Unit)
Table 52. Key Countries/Regions Interventional Ventricular Assist Devices Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Interventional Ventricular Assist Devices Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Interventional Ventricular Assist Devices Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Interventional Ventricular Assist Devices Sales Volume, (2020-2025) & (Units)
Table 56. Key Countries/Regions Interventional Ventricular Assist Devices Sales Volume, (2026-2031) & (Units)
Table 57. Abiomed, Inc. Company Information
Table 58. Abiomed, Inc. Introduction and Business Overview
Table 59. Abiomed, Inc. Interventional Ventricular Assist Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 60. Abiomed, Inc. Interventional Ventricular Assist Devices Product Offerings
Table 61. Abiomed, Inc. Recent Development
Table 62. LivaNova, Inc Company Information
Table 63. LivaNova, Inc Introduction and Business Overview
Table 64. LivaNova, Inc Interventional Ventricular Assist Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 65. LivaNova, Inc Interventional Ventricular Assist Devices Product Offerings
Table 66. LivaNova, Inc Recent Development
Table 67. Levitronix Company Information
Table 68. Levitronix Introduction and Business Overview
Table 69. Levitronix Interventional Ventricular Assist Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 70. Levitronix Interventional Ventricular Assist Devices Product Offerings
Table 71. Levitronix Recent Development
Table 72. HeartWare International Pty Ltd Company Information
Table 73. HeartWare International Pty Ltd Introduction and Business Overview
Table 74. HeartWare International Pty Ltd Interventional Ventricular Assist Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 75. HeartWare International Pty Ltd Interventional Ventricular Assist Devices Product Offerings
Table 76. HeartWare International Pty Ltd Recent Development
Table 77. PulseCath Company Information
Table 78. PulseCath Introduction and Business Overview
Table 79. PulseCath Interventional Ventricular Assist Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 80. PulseCath Interventional Ventricular Assist Devices Product Offerings
Table 81. PulseCath Recent Development
Table 82. Magenta Medical Company Information
Table 83. Magenta Medical Introduction and Business Overview
Table 84. Magenta Medical Interventional Ventricular Assist Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 85. Magenta Medical Interventional Ventricular Assist Devices Product Offerings
Table 86. Magenta Medical Recent Development
Table 87. Shenzhen Hanuo Medical Technology Co., Ltd Company Information
Table 88. Shenzhen Hanuo Medical Technology Co., Ltd Introduction and Business Overview
Table 89. Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 90. Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Offerings
Table 91. Shenzhen Hanuo Medical Technology Co., Ltd Recent Development
Table 92. Shanghai Newmed Medical Technology Co., Ltd Company Information
Table 93. Shanghai Newmed Medical Technology Co., Ltd Introduction and Business Overview
Table 94. Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 95. Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Offerings
Table 96. Shanghai Newmed Medical Technology Co., Ltd Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Interventional Ventricular Assist Devices Downstream Customers
Table 100. Interventional Ventricular Assist Devices Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Interventional Ventricular Assist Devices Product Picture
Figure 2. Global Interventional Ventricular Assist Devices Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Interventional Ventricular Assist Devices Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Interventional Ventricular Assist Devices Sales Volume (2020-2031) & (Units)
Figure 5. Global Interventional Ventricular Assist Devices Sales Price (2020-2031) & (K US$/Unit)
Figure 6. Interventional Ventricular Assist Devices Report Years Considered
Figure 7. Global Interventional Ventricular Assist Devices Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Interventional Ventricular Assist Devices Players Sales Volume Ranking (2024) & (Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Interventional Ventricular Assist Devices Revenue in 2024
Figure 10. Interventional Ventricular Assist Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. 2.5L/min Picture
Figure 12. 3.5L/min Picture
Figure 13. 5.0L/min Picture
Figure 14. 5.5L/min Picture
Figure 15. Global Interventional Ventricular Assist Devices Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Interventional Ventricular Assist Devices Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Interventional Ventricular Assist Devices Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
Figure 18. Global Interventional Ventricular Assist Devices Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Interventional Ventricular Assist Devices Price by Type (2020-2031) & (K US$/Unit)
Figure 20. Product Picture of Public Hospitals
Figure 21. Product Picture of Private Hospital
Figure 22. Global Interventional Ventricular Assist Devices Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Interventional Ventricular Assist Devices Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Interventional Ventricular Assist Devices Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
Figure 25. Global Interventional Ventricular Assist Devices Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Interventional Ventricular Assist Devices Price by Application (2020-2031) & (K US$/Unit)
Figure 27. North America Interventional Ventricular Assist Devices Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Interventional Ventricular Assist Devices Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Interventional Ventricular Assist Devices Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Interventional Ventricular Assist Devices Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Interventional Ventricular Assist Devices Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Interventional Ventricular Assist Devices Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Interventional Ventricular Assist Devices Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Interventional Ventricular Assist Devices Sales Volume (%), (2020-2031)
Figure 39. United States Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Interventional Ventricular Assist Devices Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Interventional Ventricular Assist Devices Sales Value by Application (%), 2024 VS 2031
Figure 45. China Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
Figure 47. China Interventional Ventricular Assist Devices Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Interventional Ventricular Assist Devices Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Interventional Ventricular Assist Devices Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Interventional Ventricular Assist Devices Sales Value by Application (%), 2024 VS 2031
Figure 57. India Interventional Ventricular Assist Devices Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Interventional Ventricular Assist Devices Sales Value by Type (%), 2024 VS 2031
Figure 59. India Interventional Ventricular Assist Devices Sales Value by Application (%), 2024 VS 2031
Figure 60. Interventional Ventricular Assist Devices Industrial Chain
Figure 61. Interventional Ventricular Assist Devices Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 12.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Interventional Ventricular Assist Devices market size from 2025 to 2031?
What was the global market size of Interventional Ventricular Assist Devices in 2031?
Which companies rank high in the global Interventional Ventricular Assist Devices market?
What was the global market size of Interventional Ventricular Assist Devices in 2025?
Related Reports
Global Interventional Ventricular Assist Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Interventional Ventricular Assist Devices market is projected to grow from US$ 1826 million in 2025 to US$ 4019 million by 2032, at a CAGR of 12.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 144
USD 4900.00
(Single User License)
Global Interventional Ventricular Assist Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Interventional Ventricular Assist Devices market size was US$ 1826 million in 2025 and is forecast to reach a readjusted size of US$ 4019 million by 2032 with a CAGR of 12.1% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 80
USD 4250.00
(Single User License)
Interventional Ventricular Assist Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Interventional Ventricular Assist Devices was estimated to be worth US$ 1826 million in 2025 and is projected to reach US$ 4019 million, growing at a CAGR of 12.1% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 101
USD 3950.00
(Single User License)
Global Interventional Ventricular Assist Devices Market Research Report 2026
The global Interventional Ventricular Assist Devices market was valued at US$ 1826 million in 2025 and is anticipated to reach US$ 4019 million by 2032, at a CAGR of 12.1% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 114
USD 2900.00
(Single User License)
Global Interventional Ventricular Assist Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Interventional Ventricular Assist Devices market size was US$ 1647 million in 2024 and is forecast to a readjusted size of US$ 3624 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 78
USD 4250.00
(Single User License)
Global Interventional Ventricular Assist Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Interventional Ventricular Assist Devices market is projected to grow from US$ 1647 million in 2024 to US$ 3624 million by 2031, at a CAGR of 12.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 137
USD 4900.00
(Single User License)
Global Interventional Ventricular Assist Devices Market Research Report 2025
The global market for Interventional Ventricular Assist Devices was valued at US$ 1647 million in the year 2024 and is projected to reach a revised size of US$ 3624 million by 2031, growing at a CAGR of 12.1% during the forecast period.
Published Date: 2025-03-10
Pages: 84
USD 2900.00
(Single User License)
Global Interventional Ventricular Assist Devices Market Insights, Forecast to 2030
Valued at US$ 1647 million in 2024, the global Interventional Ventricular Assist Devices market is forecast to reach US$ 3268 million by 2030, at a CAGR of 12.1% during the forecast period.
Published Date: 2024-12-19
Pages: 131
USD 4900.00
(Single User License)
Interventional Ventricular Assist Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Interventional Ventricular Assist Devices was estimated to be worth US$ 1470 million in 2023 and is forecast to a readjusted size of US$ 3268 million by 2030 with a CAGR of 12.1% during the forecast period 2024-2030.
Published Date: 2024-12-19
Pages: 97
USD 3950.00
(Single User License)
Global Interventional Ventricular Assist Devices Market Research Report 2024
The global market for Interventional Ventricular Assist Devices was valued at US$ 1470 million in the year 2023 and is projected to reach a revised size of US$ 3268 million by 2030, growing at a CAGR of 12.1% during the forecast period.
Published Date: 2024-12-19
Pages: 84
USD 2900.00
(Single User License)
Global Interventional Ventricular Assist Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Interventional Ventricular Assist Devices market is projected to grow from US$ 1826 million in 2025 to US$ 4019 million by 2032, at a CAGR of 12.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 144
USD 4900.00 (Single User License)Global Interventional Ventricular Assist Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Interventional Ventricular Assist Devices market size was US$ 1826 million in 2025 and is forecast to reach a readjusted size of US$ 4019 million by 2032 with a CAGR of 12.1% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 80
USD 4250.00 (Single User License)Interventional Ventricular Assist Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Interventional Ventricular Assist Devices was estimated to be worth US$ 1826 million in 2025 and is projected to reach US$ 4019 million, growing at a CAGR of 12.1% from 2026 to 2032.
Published: 2026-01-19
Pages: 101
USD 3950.00 (Single User License)Global Interventional Ventricular Assist Devices Market Research Report 2026
The global Interventional Ventricular Assist Devices market was valued at US$ 1826 million in 2025 and is anticipated to reach US$ 4019 million by 2032, at a CAGR of 12.1% from 2026 to 2032.
Published: 2026-01-08
Pages: 114
USD 2900.00 (Single User License)Global Interventional Ventricular Assist Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Interventional Ventricular Assist Devices market size was US$ 1647 million in 2024 and is forecast to a readjusted size of US$ 3624 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 78
USD 4250.00 (Single User License)Global Interventional Ventricular Assist Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Interventional Ventricular Assist Devices market is projected to grow from US$ 1647 million in 2024 to US$ 3624 million by 2031, at a CAGR of 12.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 137
USD 4900.00 (Single User License)Global Interventional Ventricular Assist Devices Market Research Report 2025
The global market for Interventional Ventricular Assist Devices was valued at US$ 1647 million in the year 2024 and is projected to reach a revised size of US$ 3624 million by 2031, growing at a CAGR of 12.1% during the forecast period.
Published: 2025-03-10
Pages: 84
USD 2900.00 (Single User License)Global Interventional Ventricular Assist Devices Market Insights, Forecast to 2030
Valued at US$ 1647 million in 2024, the global Interventional Ventricular Assist Devices market is forecast to reach US$ 3268 million by 2030, at a CAGR of 12.1% during the forecast period.
Published: 2024-12-19
Pages: 131
USD 4900.00 (Single User License)Interventional Ventricular Assist Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Interventional Ventricular Assist Devices was estimated to be worth US$ 1470 million in 2023 and is forecast to a readjusted size of US$ 3268 million by 2030 with a CAGR of 12.1% during the forecast period 2024-2030.
Published: 2024-12-19
Pages: 97
USD 3950.00 (Single User License)Global Interventional Ventricular Assist Devices Market Research Report 2024
The global market for Interventional Ventricular Assist Devices was valued at US$ 1470 million in the year 2023 and is projected to reach a revised size of US$ 3268 million by 2030, growing at a CAGR of 12.1% during the forecast period.
Published: 2024-12-19
Pages: 84
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now